Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Belknap

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
JAMA Dermatology|April 2, 2015
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysisSteven M Belknap, Imran Aslam, Tina Kiguradze, et al.
Academic Radiology|July 27, 2012
Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal functionPhilip Chang, Elise Saddleton, Anne E Laumann, et al.
Expert Opinion on Drug Safety|March 14, 2013
Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugsVishvas Garg, Dennis W Raisch, June M McKoy, et al.
Chest|February 14, 2007
Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithmDemetrios N Kyriacou, Paul R Yarnold, Adam C Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports projectLisa A Ladewski, Steven M Belknap, Jonathan R Nebeker, et al.
Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.
Drug Safety|April 5, 2013
Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) projectJune M McKoy, Matthew J Fisher, D Mark Courtney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylateDavid A Dorr, Rachel Burdon, Dennis P West, et al.
Pediatric Radiology|September 24, 2013
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR reportBeatrice Nardone, Elise Saddleton, Anne E Laumann, et al.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2013
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectBeatrice J Edwards, Andrew D Bunta, Joseph Lane, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
JAMA Dermatology|April 2, 2015
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysisSteven M Belknap, Imran Aslam, Tina Kiguradze, et al.
Academic Radiology|July 27, 2012
Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal functionPhilip Chang, Elise Saddleton, Anne E Laumann, et al.
Expert Opinion on Drug Safety|March 14, 2013
Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugsVishvas Garg, Dennis W Raisch, June M McKoy, et al.
Chest|February 14, 2007
Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithmDemetrios N Kyriacou, Paul R Yarnold, Adam C Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports projectLisa A Ladewski, Steven M Belknap, Jonathan R Nebeker, et al.
Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.
Drug Safety|April 5, 2013
Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) projectJune M McKoy, Matthew J Fisher, D Mark Courtney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylateDavid A Dorr, Rachel Burdon, Dennis P West, et al.
Pediatric Radiology|September 24, 2013
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR reportBeatrice Nardone, Elise Saddleton, Anne E Laumann, et al.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2013
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectBeatrice J Edwards, Andrew D Bunta, Joseph Lane, et al.
Pageof 3